PHOTO: Former Food and Drug Administration commissioner Dr. Scott Gottlieb
Former Food and Drug Administration commissioner Dr. Scott Gottlieb told CNBC's "SquawkBox" on Monday the late-stage coronavirus vaccine trials underway in the U.S. are unlikely to have gathered enough evidence to receive emergency approval ahead of the November presidential election.
Gottlieb said, “I think it’s very unlikely. I think it’s more likely you’re going to get a top-line result some point in November and maybe be able to make a decision about an emergency use authorization after that.
The former FDA chief, Gottlieb, also sits on the board of Pfizer, which is developing a vaccine to prevent Covid-19.
Dr. Gottlieb added the more effective the vaccine is, the sooner the trial is likely to generate data on effectiveness.
More: CNBC.COM